Bottom line
What does RXL hold?
RXL held 70 positions as of May 31, 2026. Its largest holding is Eli Lilly & Co. at 12.67% of the fund, and the top 10 positions add up to 57.8%. By asset type it is 78% stocks, 7% repurchase agreements, 12% other.
Updated Jul 28, 2026
RXL top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co. | Stocks | 12.67% | $9.1M |
| 2 | ProShares GENIUS Money Market ETF | Other | 11.81% | $8.5M |
| 3 | Johnson & Johnson | Stocks | 7.86% | $5.7M |
| 4 | AbbVie, Inc. | Stocks | 5.57% | $4.0M |
| 5 | UnitedHealth Group, Inc. | Stocks | 4.98% | $3.6M |
| 6 | Merck & Co., Inc. | Stocks | 4.26% | $3.1M |
| 7 | Repurchase Agreement | Repurchase agreements | 2.91% | $2.1M |
| 8 | Thermo Fisher Scientific, Inc. | Stocks | 2.68% | $1.9M |
| 9 | Amgen, Inc. | Stocks | 2.62% | $1.9M |
| 10 | Gilead Sciences, Inc. | Stocks | 2.41% | $1.7M |
| 11 | Intuitive Surgical, Inc. | Stocks | 2.18% | $1.6M |
| 12 | Pfizer, Inc. | Stocks | 2.15% | $1.6M |
| 13 | Abbott Laboratories | Stocks | 2.15% | $1.6M |
| 14 | Repurchase Agreement | Repurchase agreements | 1.83% | $1.3M |
| 15 | Bristol-Myers Squibb Co. | Stocks | 1.68% | $1.2M |
| 16 | CVS Health Corp. | Stocks | 1.67% | $1.2M |
| 17 | Danaher Corp. | Stocks | 1.66% | $1.2M |
| 18 | Vertex Pharmaceuticals, Inc. | Stocks | 1.64% | $1.2M |
| 19 | Stryker Corp. | Stocks | 1.52% | $1.1M |
| 20 | Repurchase Agreement | Repurchase agreements | 1.37% | $989.6K |
| 21 | Medtronic plc | Stocks | 1.37% | $986.8K |
| 22 | McKesson Corp. | Stocks | 1.32% | $948.1K |
| 23 | Elevance Health, Inc. | Stocks | 1.26% | $904.7K |
| 24 | Cigna Group (The) | Stocks | 1.06% | $762.0K |
| 25 | Boston Scientific Corp. | Stocks | 1.04% | $747.1K |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 28, 2026